Wildwood, MO, United States of America

Rodney G Combs

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Transtech Pharma, Inc.. Active years: 2015.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rodney G Combs: Innovator in RAGE Fusion Protein Research

Introduction

Rodney G Combs is a notable inventor based in Wildwood, MO (US). He has made significant contributions to the field of biotechnology, particularly in the area of RAGE fusion proteins. His innovative work has led to the development of methods that enhance the understanding and application of these proteins in various medical contexts.

Latest Patents

Rodney G Combs holds a patent for "Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions." This invention relates to methods for controlling the glycosylation of a RAGE fusion protein. The patent also covers compositions that include a RAGE fusion protein, where at least 0.5% of the protein is aglycosylated, and no more than 53.2% of the protein is aglycosylated. This patent highlights his expertise and innovative approach in the field, with a total of 1 patent to his name.

Career Highlights

Rodney is currently associated with Transtech Pharma, Inc., where he continues to advance his research and development efforts. His work at Transtech Pharma has positioned him as a key player in the biotechnology sector, contributing to the company's mission of developing innovative therapeutic solutions.

Collaborations

Rodney has collaborated with several talented individuals in his field, including Susanna Roe and Derrick L Ruble. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared research interests.

Conclusion

Rodney G Combs is a distinguished inventor whose work on RAGE fusion proteins has the potential to impact medical research significantly. His contributions through patents and collaborations reflect his commitment to advancing biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…